SBC Medical Takes Minority Stake in OrangeTwist to Enter U.S. Market

Reuters
Jan 05
SBC Medical Takes Minority Stake in OrangeTwist to Enter U.S. Market

SBC Medical Group Holdings Inc. has completed a strategic minority equity investment and established a structured collaboration framework with OrangeTwist, a leading U.S.-based MedSpa chain. The transaction marks SBC Medical’s formal entry into the United States medical aesthetics market and is a significant step in the company’s broader global expansion strategy. As part of the agreement, SBC Medical and OrangeTwist will pursue joint operations and leverage cross-border synergies between the U.S. and Asia to support long-term growth. OrangeTwist, founded in 2015, operates 24 locations across six states and specializes in non-invasive aesthetic treatments. This partnership is supported by OrangeTwist’s institutional shareholders, Hildred Capital and Athyrium Capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SBC Medical Group Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251210926005) on January 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10